CompletedNot Applicable

Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

Turkey (Türkiye)48 participantsStarted 2020-11-17

Plain-language summary

This study aimed to investigate the relationship between latent MTrPs and gluteus medius muscle strength in a group of healthy adults.

Who can participate

Age range

18 Years – 40 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient age: 18-40 years. * Absence of musculoskeletal complaints related to the lumbar, sacroiliac, and hip area. * Absence of bilateral latent MTrP in the gluteus medius muscle. * Latent trigger point in the gluteus medius muscle on the dominant side with palpation. Exclusion Criteria: * A history of medical treatment, physical therapy, injection therapy, or surgical treatment related to the lumbar, sacroiliac, and hip area. * History of trauma, or malignancy or being pregnant, or if the patient is in the lactation period. * Bilateral latent MTrP in the gluteus medius muscle. * Presence of latent MTrP on the non-dominant side.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Gluteus medius muscle strength

Timeframe: One month

Trial details

NCT IDNCT04640558

SponsorKars State Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-17

View on ClinicalTrials.gov More Myofascial Pain Syndrome trials